1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Substance Abuse Treatment Market
2.3. Global Substance Abuse Treatment Market, By Treatment, 2025 (US$ Million)
2.4. Global Substance Abuse Treatment Market, By Geography, 2025 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2025
3. Substance Abuse Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Substance Abuse Treatment Market Vendors
3.2. Strategies Adopted by Substance Abuse Treatment Market Vendors
4. Substance Abuse Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Substance Abuse Treatment Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape
5. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Alcohol Addiction Treatment
5.3.1.1. Disulfiram
5.3.1.2. Acamprosate
5.3.1.3. Naltrexone
5.3.2. Tobacco/ Nicotine Addiction Treatment
5.3.2.1. Nicotine Replacement Treatment
5.3.2.1.1. Nicotine Patch
5.3.2.1.2. Nicotine Gum
5.3.2.1.3. Nicotine Lozenges
5.3.2.1.4. Nicotine Spray
5.3.2.1.5. Nicotine Inhaler
5.3.2.2. Non-Nicotine Medication
5.3.2.2.1. Bupropion
5.3.2.2.2. Varenicline
5.3.2.3. Drug Abuse Treatment
5.3.2.3.1. Methadone
5.3.2.3.2. Buprenorphine
5.3.2.3.3. Naltrexone
6. North America Substance Abuse Treatment Market, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
6.3. Substance Abuse Treatment Market: By Region, 2024-2034, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
7. UK and European Union Substance Abuse Treatment Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
7.3. Substance Abuse Treatment Market: By Region, 2024-2034, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
7.3.1.5. France
7.3.1.5.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
8. Asia Pacific Substance Abuse Treatment Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
8.3. Substance Abuse Treatment Market: By Region, 2024-2034, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
8.3.1.3. India
8.3.1.3.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
9. Latin America Substance Abuse Treatment Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
9.3. Substance Abuse Treatment Market: By Region, 2024-2034, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
10. Middle East and Africa Substance Abuse Treatment Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
10.3. Substance Abuse Treatment Market: By Region, 2024-2034, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Substance Abuse Treatment Market: By Treatment, 2024-2034, USD (Million)
11. Company Profile
11.1. Alkermes Plc. (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Allergan
11.3. Forest Laboratories, Inc.
11.4. GlaxoSmithKline Plc.
11.5. Mylan Laboratories
11.6. Pfizer Inc.
11.7. Purdue Pharma LP
11.8. Reckitt Benckiser Pharmaceuticals
11.9. Teva Pharmaceuticals
